Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year



Series A | Alive

Total Raised


Last Raised

$8M | 21 yrs ago

About Exponential Biotherapies

Developer of small molecule drugs designed to treat a wide range of severe inflammatory disorders. These disorders include septic shock, radiation sickness, and avian influenza. The company's compounds represent a new class of immune regulating therapeutic agents.

Exponential Biotherapies Headquarter Location

248 East 44th Street 2nd Floor

New York, New York, 10017,

United States


Latest Exponential Biotherapies News

Global Acute Renal Failure (ARF) Market Is Growing At A CAGR Of 5.10% | Angion, Quark, AM-Pharma B.V., Atox Bio, Astellas Pharma Inc., Pharming, MediBeacon, Exponential Biotherapies, Sequens, Pfizer

Mar 9, 2021

Search jobs 09-Mar-2021 Global Acute Renal Failure (ARF) Market Is Growing At A CAGR Of 5.10% | Angion, Quark, AM-Pharma B.V., Atox Bio, Astellas Pharma Inc., Pharming, MediBeacon, Exponential Biotherapies, Sequens, Pfizer DBMR has added a new report titled Global Acute Renal Failure (ARF) Market with data Tables for historical and forecast years represented with Charts & Graphs spread through Pages with easy to understand detailed analysis. This also Report has also been compiled to provide various market aspects such as size, share, trends, dynamics, growth, sales, and industry analysis. The competitive analysis taken place in this report include strategic profiling of key market players, their core competencies, their strong and weak points, and competitive landscape of the market which supports businesses illustrate their individual strategies. Acute  renal  failure (ARF) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 5.10% in the above-mentioned research forecast period. Rising geriatric population and increasing burden of acute renal failure among others. Rising obese and diabetic population and increasing incidence of dengue, malaria and leptospirosis also boost up the market growth. Moreover, increasing research and development, presence of pipeline drugs and rising healthcare expenditure act as opportunity for the market growth. But, sometimes adverse effect caused by medications, lack of caregiver coordination and strict regulatory framework for drug approval may hamper the global acute renal failure (ARF) market. This acute renal failure (ARF) market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an  Analyst Brief ,  our team will help you create a revenue impact solution to achieve your desired goal. This Free report sample includes: A brief introduction to the research report. Graphical introduction of the regional analysis. Top players in the market with their revenue analysis. Selected illustrations of market insights and trends. Example pages from the report. The countries covered in the Acute renal failure (ARF) market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa. For More Insights Get FREE Detailed TOC @ Competitive Landscape and Acute Renal Failure (ARF) Market Share Analysis Acute renal failure (ARF) market competitive landscape provides details by competitor. details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Acute renal failure (ARF) market. The major players covered in the Acute renal failure (ARF) market are Alloksys, Angion, Quark, AM-Pharma B.V., Atox Bio, Astellas Pharma Inc., Pharming, MediBeacon, Exponential Biotherapies, Sequens, Pfizer Inc., Solvay, Leisha Pharma Solutions Pvt. Ltd., Merck KGaA, Wacker Chemie AG, Hetero Healthcare Limited., Zydus Cadila, Dr. Reddy’s Laboratories, Novartis AG, Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceutical Inc among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. Why Choose DBMR? Pre-commodity pricing volatility About Data Bridge Market Research: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate. Contact Us:-

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Exponential Biotherapies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Exponential Biotherapies is included in 1 Expert Collection, including Biopharmaceuticals.



5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Exponential Biotherapies Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Exponential Biotherapies Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.